Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils
- PMID: 8046346
- PMCID: PMC2191606
- DOI: 10.1084/jem.180.2.711
Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils
Abstract
In this study we have investigated the effects of interleukin 10 (IL-10) on human peripheral blood eosinophils stimulated with granulocyte/macrophage colony stimulating factor (GM-CSF) and lipopolysaccharide (LPS). We show that LPS was able to enhance eosinophil survival in a dose-dependent manner, as well as release of the cytokines GM-CSF, tumor necrosis factor alpha, and IL-8. LPS-induced eosinophil survival was largely inhibited by an anti-GM-CSF neutralizing antibody and completely blocked by polymyxin B, suggesting GM-CSF involvement in the survival enhancing mechanism and LPS specificity, respectively. IL-10 significantly inhibited survival of, and cytokine production from, eosinophils induced by LPS, but did not inhibit the survival induced by GM-CSF. These observations suggest a novel activation mechanism of eosinophils and, also, that IL-10 may participate in the regulation of diseases characterized by eosinophil infiltration.
Similar articles
-
Allergen activates peripheral blood eosinophil nuclear factor-kappaB to generate granulocyte macrophage-colony stimulating factor, tumour necrosis factor-alpha and interleukin-8.Clin Exp Allergy. 2004 Jul;34(7):1071-8. doi: 10.1111/j.1365-2222.2004.02003.x. Clin Exp Allergy. 2004. PMID: 15248852
-
Dexamethasone inhibits prolonged survival and autocrine granulocyte-macrophage colony-stimulating factor production by human eosinophils cultured on laminin or tissue fibronectin.J Allergy Clin Immunol. 1997 Aug;100(2):208-15. doi: 10.1016/s0091-6749(97)70226-4. J Allergy Clin Immunol. 1997. PMID: 9275142
-
Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor.J Immunol. 1998 Jun 1;160(11):5554-62. J Immunol. 1998. PMID: 9605160
-
Eokines: synthesis, storage and release from human eosinophils.Mem Inst Oswaldo Cruz. 1997;92 Suppl 2:125-33. doi: 10.1590/s0074-02761997000800017. Mem Inst Oswaldo Cruz. 1997. PMID: 9698924 Review.
-
Cytokine generation by eosinophils.J Allergy Clin Immunol. 1994 Dec;94(6 Pt 2):1183-8. doi: 10.1016/0091-6749(94)90330-1. J Allergy Clin Immunol. 1994. PMID: 7798558 Review. No abstract available.
Cited by
-
Trans-basement membrane migration of eosinophils induced by LPS-stimulated neutrophils from human peripheral blood in vitro.ERJ Open Res. 2015 Dec 22;1(2):00003-2015. doi: 10.1183/23120541.00003-2015. eCollection 2015 Oct. ERJ Open Res. 2015. PMID: 27730145 Free PMC article.
-
Toxoplasma gondii infection blocks the development of allergic airway inflammation in BALB/c mice.Clin Exp Immunol. 2009 Feb;155(2):275-84. doi: 10.1111/j.1365-2249.2008.03813.x. Epub 2008 Nov 20. Clin Exp Immunol. 2009. PMID: 19032550 Free PMC article.
-
The role of regulatory T cells in allergic rhinitis and their correlation with IL-10, IL-17 and neopterin levels in serum and nasal lavage fluid.Eur Arch Otorhinolaryngol. 2020 Apr;277(4):1109-1114. doi: 10.1007/s00405-020-05811-4. Epub 2020 Jan 28. Eur Arch Otorhinolaryngol. 2020. PMID: 31993765
-
IL-10+ regulatory B cells mitigate atopic dermatitis by suppressing eosinophil activation.Sci Rep. 2024 Aug 6;14(1):18164. doi: 10.1038/s41598-024-68660-9. Sci Rep. 2024. PMID: 39107352 Free PMC article.
-
Antiallergic Function of KR62980, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in a Mouse Allergic Rhinitis Model.Allergy Asthma Immunol Res. 2015 May;7(3):256-64. doi: 10.4168/aair.2015.7.3.256. Epub 2015 Mar 5. Allergy Asthma Immunol Res. 2015. PMID: 25749778 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources